Net Loss Per Common Share (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | ||||||||||||||||||||||||||||||||||||
| Net Loss Per Common Share | ||||||||||||||||||||||||||||||||||||
| Schedule of anti dilutive securities excluded from the computation of diluted weighted average shares |
The following potentially dilutive securities outstanding for the years ended September 30, 2022 and 2021 have been excluded from the computation of diluted weighted-average shares outstanding, as they would be anti-dilutive:
|
|||||||||||||||||||||||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|